Compounds > emodin

emodin and myricetin

emodin has been researched along with myricetin in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (15.38)	18.2507
2000's	3 (23.08)	29.6817
2010's	6 (46.15)	24.3611
2020's	2 (15.38)	2.80

Authors

Authors	Studies
Chang, CJ; Geahlen, RL	1
Abou-Shoer, M; Chang, CJ; Geahlen, RL; Koonchanok, NM; Li, XH; Ma, GE	1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J	1
Arioka, S; Hinou, H; Nishimura, S; Sakagami, M; Takemoto, H; Togame, H; Uematsu, R; Yamaguchi, H	1
Brattain, MG; Sabbah, DA; Simms, NA; Vennerstrom, JL; Zhong, H	1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P	1
Bulic, B; Mandelkow, E; Pickhardt, M	1
Dutour, R; Poirier, D	1
Golonko, A; Lazny, R; Lewandowski, W; Pienkowski, T; Roszko, M; Swislocka, R	1
Bernatchez, JA; Li, J; Li, R; Luan, Y; Siqueira-Neto, JL; Tran, LT	1
Bardine, C; Craik, CS; O'Donnell, HR; Shoichet, BK; Tummino, TA	1
Li, GK; Wang, JX; Xiao, XH	1

Reviews

5 review(s) available for emodin and myricetin

Article	Year
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents. Journal of natural products, 1992, Volume: 55, Issue:11 Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Protein-Tyrosine Kinases	1992
Progress and developments in tau aggregation inhibitors for Alzheimer disease. Journal of medicinal chemistry, 2013, Jun-13, Volume: 56, Issue:11 Topics: Alzheimer Disease; Animals; Clinical Trials as Topic; Humans; Hydrogen Bonding; Models, Molecular; Protein Binding; Protein Conformation; Structure-Activity Relationship; tau Proteins	2013
Inhibitors of cytochrome P450 (CYP) 1B1. European journal of medicinal chemistry, 2017, Jul-28, Volume: 135 Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship	2017
Another look at phenolic compounds in cancer therapy the effect of polyphenols on ubiquitin-proteasome system. European journal of medicinal chemistry, 2019, Apr-01, Volume: 167 Topics: Animals; Diet; Humans; Neoplasms; Phenols; Polyphenols; Proteasome Endopeptidase Complex; Ubiquitin	2019
Drugs for the Treatment of Zika Virus Infection. Journal of medicinal chemistry, 2020, 01-23, Volume: 63, Issue:2 Topics: Animals; Antiviral Agents; Drug Development; Drug Discovery; Humans; Viral Vaccines; Zika Virus; Zika Virus Infection	2020

Other Studies

8 other study(ies) available for emodin and myricetin

Article	Year
Flavonoids from Koelreuteria henryi and other sources as protein-tyrosine kinase inhibitors. Journal of natural products, 1993, Volume: 56, Issue:6 Topics: Animals; Cattle; Flavonoids; Kaempferols; Magnetic Resonance Spectroscopy; Plant Extracts; Plants; Protein-Tyrosine Kinases; Quercetin	1993
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nature chemical biology, 2009, Volume: 5, Issue:10 Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection	2009
Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase. Bioorganic & medicinal chemistry, 2010, Feb-15, Volume: 18, Issue:4 Topics: Base Sequence; DNA Primers; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glycoproteins; Neuraminidase; Recombinant Proteins; Structure-Activity Relationship; Trypanosoma cruzi	2010
Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases. Bioorganic & medicinal chemistry letters, 2012, Jan-15, Volume: 22, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Stereoisomerism; Structure-Activity Relationship	2012
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22 Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship	2012
Colloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens. Journal of medicinal chemistry, 2021, 12-09, Volume: 64, Issue:23 Topics: Antiviral Agents; COVID-19 Drug Treatment; Drug Repositioning; Molecular Docking Simulation	2021
Study of vacuum microwave-assisted extraction of polyphenolic compounds and pigment from Chinese herbs. Journal of chromatography. A, 2008, Jul-11, Volume: 1198-1199 Topics: Chemical Fractionation; Coloring Agents; Coumaric Acids; Drugs, Chinese Herbal; Emodin; Flavonoids; Glucosides; Microwaves; Myrica; Phenols; Plant Leaves; Polyphenols; Quercetin; Reproducibility of Results; Resveratrol; Stilbenes; Vacuum	2008